Thor Medical ASA (OSL:TRMED)

Norway flag Norway · Delayed Price · Currency is NOK
4.220
-0.030 (-0.71%)
At close: Dec 5, 2025
21.26%
Market Cap 1.49B
Revenue (ttm) 100.00K
Net Income (ttm) -58.91M
Shares Out 352.99M
EPS (ttm) -0.22
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,510,228
Average Volume 2,081,488
Open 4.255
Previous Close 4.250
Day's Range 4.200 - 4.290
52-Week Range 1.804 - 4.800
Beta 0.08
RSI 60.20
Earnings Date Feb 26, 2026

About Thor Medical ASA

Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. It develops Ra224, an isotope of radium; Pb-212, a radioactive isotope of lead; and Th-228, a radioactive isotope of thorium. The company was incorporated in 2009 and is headquartered in Oslo, Norway. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2009
Employees 9
Stock Exchange Oslo Børs
Ticker Symbol TRMED
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.